A new promising treatment in systemic sclerosis: 5-fluorouracil

Academic Article


  • Twelve patients with systemic sclerosis according to American Rheumatism Association criteria were treated with intravenous 5-fluorouracil. Significant subjective and objective improvement occurred initially in the skin and subsequently in the involved viscera and vasculature. These preliminary results suggest that 5-fluorouracil may be an effective treatment for systemic sclerosis.
  • Published In

    Digital Object Identifier (doi)

    Author List

  • Casas JA; Subauste CP; Alarc√≥n GS
  • Start Page

  • 763
  • End Page

  • 767
  • Volume

  • 46
  • Issue

  • 10